Nexus Pharmaceuticals
Srujana Madabhushini is an experienced analytical scientist currently employed at Nexus Pharmaceuticals, Inc. since April 2022, holding the position of Analytical Scientist-II. Prior to this role, Srujana worked as a Senior Chemist in Analytical R&D at Odin Pharmaceuticals, LLC from May 2019 to March 2022, and as an Analytical Chemist at Lupin from December 2015 to May 2019. Srujana earned a Master of Science in Chemistry from Texas A&M University-Kingsville between 2013 and 2015 and a Bachelor of Technology in Chemical Engineering from Sathyabama Institute of Science & Technology, Chennai from 2009 to 2013.
Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-owned healthcare company and proud diverse supplier. We specialize in innovative processes to make difficult-to-manufacture specialty drugs that are easier to use, less labor-intensive, and more streamlined in practice. Nexus ensures that its high-quality, FDA-approved drugs fulfill a critical, unmet medical need and delivers dependable life-saving treatment options when and where they’re needed most. We are in the process of building Project Tomorrow – a state-of-the-art manufacturing facility in Pleasant Prairie, Wisconsin and only project of its kind in the last 30 years. Read about our commitment to Wisconsin and see our progress at nexuspharma.net/project-tomorrow